TP53 and acute lymphoblastic leukemia: Inhibiting SYK in vitro downregulated the expression of p53 in pro-B-ALL (SEM cells) (34), HCT116, and HT1080 cell lines (25), which highlights the effect of SYK inhibition on p53 expression and activity.